非小细胞肺癌围手术期结局的十年改善分析
该研究回顾性分析760例接受肺切除术的非小细胞肺癌患者,按2011-2015年与2016-2020年分为早期和晚期组。晚期组患者更年长、合并症更多、分期更早,但术后并发症和严重并发症更少、术后住院更短;总生存有差异而无进展生存差异。
要点
- 晚期组肺叶或扩大切除、开胸手术比例显著降低,术后并发症及严重并发症减少。
- 肺叶或扩大切除是术后并发症和严重并发症的显著危险因素。
- 早期组和肺叶或扩大切除是严重并发症的显著危险因素。
核心结论
- 随着时间推移,年长且合并症更多的患者术后并发症发生率下降。
- 非小细胞肺癌患者预后未随VATS或亚肺叶切除增加而改变。
研究设计与样本
- 回顾性研究,收集过去十年760例接受肺切除术的非小细胞肺癌患者临床数据。
- 按2011-2015年(早期)和2016-2020年(晚期)分组,分析患者特征、手术方式、围手术期因素、术后并发症和预后变化。
主要发现
- 晚期组患者更年长(p=0.01)、合并症更多(p=0.01)、癌症分期更早(p<0.01)。
- 晚期组肺叶或扩大切除手术显著减少(p<0.01),开胸手术显著减少(p<0.01)。
- 晚期组术后并发症(p=0.02)和严重并发症(p<0.01)显著减少,术后住院时间显著缩短。
- 肺叶或扩大切除是术后并发症的显著危险因素(p<0.01)。
- 早期组(p<0.01)和肺叶或扩大切除(p<0.01)是严重术后并发症的显著危险因素。
临床怎么用
- 对于年长且合并症多的非小细胞肺癌患者,VATS和亚肺叶切除的应用可能与术后并发症减少相关。
- 肺叶或扩大切除与术后并发症风险增加相关,围手术期管理需关注。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 单中心数据,样本量760例,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Video-assisted thoracic surgery (VATS) procedures for non-small cell lung cancer (NSCLC) have steadily increased and have become the gold standard, but their prognostic advantage compared with thoracotomy has not been elucidated. This study retrospectively evaluated perioperative characteristics of VATS for NSCLC over time. METHODS: We collected the clinical data of 760 patients with NSCLC who underwent pulmonary resection over the past decade, classifying patients into early (2011-2015) and late (2016-2020) periods. Changes in NSCLC patient characteristics, surgical approaches, perioperative factors, postoperative morbidities, and prognoses were analyzed. RESULTS: Patients in the late period were older (p = 0.01), had more comorbidities (p = 0.01), and had earlier-stage cancer (p < 0.01) than those in the early period. The late period had significantly fewer surgical procedures for lobectomy or extended resection beyond lobectomy (p < 0.01), open thoracotomies (p < 0.01), postoperative (p = 0.02) and severe morbidities (p < 0.01), and a significantly shorter postoperative hospital stay than the early period. Surgical procedures of lobectomy or extended resection beyond lobectomy (p < 0.01) were significant risk factors for postoperative morbidity, and being in the early period (p < 0.01) and surgical procedures of lobectomy or extended resection beyond lobectomy (p < 0.01) were significant risk factors for severe postoperative morbidities. The overall survival prognosis significantly differed between the groups (p = 0.02) but progression-free survival did not (p = 0.89). CONCLUSIONS: The incidence of postoperative morbidities decreased over time in older patients and patients with more comorbidities. The prognosis of patients with NSCLC did not change with increasing VATS or sublobar resection.
引用
- Motono N, Mizoguchi T, Ishikawa M, et al. Improvements in perioperative outcomes for non-small cell lung cancer: a decade-long analysis. Surg Endosc. 2022. PMID: 35896840. doi:10.1007/s00464-022-09471-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。